A股異動丨數字經濟集體走強,中國科傳等多股升停,發改委強調持續做強做優做大我國數字經濟
格隆匯4月19日丨中科信息20CM、太極股份、中國科傳升停,匯納科技升超11%,中科曙光逼近升停,富春股份、星網鋭捷、同方股份、四川長虹等跟升。消息面上,國家發改委新聞發言人孟瑋今日在新聞發佈會上表示,將重點從制度建設、數字基礎設施、產業創新發展、數字化轉型和國際合作五方面發力,持續做強做優做大我國數字經濟。另外,人民日報發文強調“推動數字經濟高質量發展”指出,必須加快實施創新驅動發展戰略,充分發揮我國社會主義制度優勢,健全新型舉國體制,瞄準全球數字技術基礎前沿領域和我國數字技術薄弱環節,集中力量推進關鍵核心技術攻關,牢牢掌握數字經濟發展主動權。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.